​

Tango Therapeutics (TNGX) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

Tango Therapeutics Revenue Highlights

Latest Revenue (Y)

$36.53M

Latest Revenue (Q)

$11.61M

Main Segment (Y)

Collaboration Revenue

Main Geography (Y)

Collaboration Revenue

Tango Therapeutics Revenue by Period

Tango Therapeutics Revenue by Year

DateRevenueChange
2023-12-31$36.53M46.93%
2022-12-31$24.86M-32.89%
2021-12-31$37.04M383.83%
2020-12-31$7.66M-68.94%
2019-12-31$24.65M-

Tango Therapeutics generated $36.53M in revenue during NA 2023, up 46.93% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Tango Therapeutics Revenue by Quarter

DateRevenueChange
2024-09-30$11.61M-41.60%
2024-06-30$19.88M207.14%
2024-03-31$6.47M19.15%
2023-12-31$5.43M-49.39%
2023-09-30$10.73M-26.48%
2023-06-30$14.60M153.17%
2023-03-31$5.77M-10.06%
2022-12-31$6.41M-7.36%
2022-09-30$6.92M19.91%
2022-06-30$5.77M0.23%
2022-03-31$5.76M0.73%
2021-12-31$5.72M-15.78%
2021-09-30$6.79M-62.61%
2021-06-30$18.15M184.26%
2021-03-31$6.39M-30.15%
2020-12-31$9.14M-181.18%
2020-09-30$-11.26M-322.37%
2020-06-30$5.06M7.49%
2020-03-31$4.71M-

Tango Therapeutics generated $11.61M in revenue during Q3 2024, up -41.60% compared to the previous quarter, and up 79.51% compared to the same period a year ago.

Tango Therapeutics Revenue Breakdown

Tango Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21
License Revenue$5.00M$11.00M-
Collaboration Revenue$31.53M$24.86M$26.04M

Tango Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Collaboration Revenue (86.31%), and License Revenue (13.69%).

Quarterly Revenue by Product

Product/ServiceSep 24Dec 23Sep 23Jun 23Dec 22Sep 22Jun 22Dec 21Sep 21
Collaboration Revenue$11.61M$11.20M$10.73M$9.60M$6.41M$6.92M$5.77M$5.72M$6.79M
License Revenue$12.10M-$5.00M$5.00M-$11.00M---

Tango Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: License Revenue (51.04%), and Collaboration Revenue (48.96%).

Tango Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Dec 21
Collaboration Revenue$24.86M$26.04M
License Revenue-$11.00M

Tango Therapeutics's latest annual revenue breakdown by geography, as of Dec 22: Collaboration Revenue (100.00%).

Tango Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
KYMRKymera Therapeutics$78.59M$3.74M
ARVNArvinas$78.50M$102.40M
NRIXNurix Therapeutics$76.99M$12.59M
TNGXTango Therapeutics$36.53M$11.61M
FHTXFoghorn Therapeutics$34.16M$7.81M
RLAYRelay Therapeutics$25.55M-
RVMDRevolution Medicines$11.58M-
STOKStoke Therapeutics$8.78M$4.89M
STTKShattuck Labs$1.66M$1.61M
PLRXPliant Therapeutics$1.58M-
CGEMCullinan Oncology--
RAPTRAPT Therapeutics--
BDTXBlack Diamond Therapeutics--
RLYBRallybio-$299.00K
CNTBConnect Biopharma--
PASGPassage Bio--
MLYSMineralys Therapeutics--
THRDThird Harmonic Bio--
GLUEMonte Rosa Therapeutics-$4.70M
EWTXEdgewise Therapeutics--
TYRATyra Biosciences--
XLOXilio Therapeutics-$2.36M

TNGX Revenue FAQ

What is Tango Therapeutics’s yearly revenue?

Tango Therapeutics's yearly revenue for 2023 was $36.53M, representing an increase of 46.93% compared to 2022. The company's yearly revenue for 2022 was $24.86M, representing a decrease of -32.89% compared to 2021. TNGX's yearly revenue for 2021 was $37.04M, representing an increase of 383.83% compared to 2020.

What is Tango Therapeutics’s quarterly revenue?

Tango Therapeutics's quarterly revenue for Q3 2024 was $11.61M, a -41.60% decrease from the previous quarter (Q2 2024), and a 8.15% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $19.88M, a 207.14% increase from the previous quarter (Q1 2024), and a 36.15% increase year-over-year (Q2 2023). TNGX's quarterly revenue for Q1 2024 was $6.47M, a 19.15% increase from the previous quarter (Q4 2023), and a 12.23% increase year-over-year (Q1 2023).

What is Tango Therapeutics’s revenue growth rate?

Tango Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -1.39%, and for the last 5 years (2019-2023) was 48.19%.

What are Tango Therapeutics’s revenue streams?

Tango Therapeutics's revenue streams in c 23 are License Revenue, and Collaboration Revenue. License Revenue generated $5M in revenue, accounting 13.69% of the company's total revenue, down -54.55% year-over-year. Collaboration Revenue generated $31.53M in revenue, accounting 86.31% of the company's total revenue, up 26.82% year-over-year.

What is Tango Therapeutics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Tango Therapeutics was Collaboration Revenue. This segment made a revenue of $31.53M, representing 86.31% of the company's total revenue.